High Expression of CARM1 Inhibits Lung Cancer Progression by Targeting TP53 by Regulating CTNNB1-Reference-Cited by-同舟云学术

High Expression of CARM1 Inhibits Lung Cancer Progression by Targeting TP53 by Regulating CTNNB1

Published:2020-02-07 Issue:2 Volume:198 Page:415-422
ISSN:0341-2040
Container-title:Lung
language:en
Short-container-title:Lung

Author:

Hu Bing,Li Xin,Chen Ling,Liu Zhongliang^ORCID

Funder

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Dragon Medical Scholars (Nursery Program) of National Clinical Research Base of Traditional Chinese Medicine

National Clinical Research Base of Traditional Chinese Medicine

Zhoushan Traditional Chinese Medicine Hospital, Zhoushan Science and Technology Project

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00408-020-00324-7.pdf

Reference19 articles.

1. Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5–29. https://doi.org/10.3322/caac.21254

2. Miranda TB, Miranda M, Frankel A, Clarke S (2004) PRMT7 Is a member of the protein arginine methyltransferase family with a distinct substrate specificity. J Biol Chem 279:22902–22907. https://doi.org/10.1074/jbc.M312904200

3. Elakoum R, Gauchotte G, Oussalah A et al (2014) CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features. Biochimie 97:210–218. https://doi.org/10.1016/j.biochi.2013.10.021

4. An W, Kim J, Roeder RG (2004) Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 117:735–748. https://doi.org/10.1016/j.cell.2004.05.009

5. Cheng H, Qin Y, Fan H et al (2013) Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes. Diagn Pathol 8:129. https://doi.org/10.1186/1746-1596-8-129

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of arginine methylation in tumorigenesis;Frontiers in Molecular Biosciences;2024-06-07

2. Integrating UPLC-Q-Orbitrap MS with serum pharmacochemistry network and experimental verification to explore the pharmacological mechanisms of Cynanchi stauntonii rhizoma et radix against sepsis-induced acute lung injury;Frontiers in Pharmacology;2024-03-22

3. Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance;Biochemical Pharmacology;2024-03

4. The protein arginine methyltransferase family (PRMTs) regulates metastases in various tumors: From experimental study to clinical application;Biomedicine & Pharmacotherapy;2023-11

5. Inhibition of CARM1 suppresses proliferation of multiple myeloma cells through activation of p53 signaling pathway;Molecular Biology Reports;2023-07-21